Jan 13, 2021 / 03:00PM GMT
Cory William Kasimov - JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst
Good morning, everyone, from the Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov, and it's my pleasure to introduce our next company, Alkermes, and Chairman and CEO, Richard Pops. Please note that following this presentation, we will have a Q&A session where you have the ability to submit questions via the conference portal.
So with that, Rich, thanks for being here, and let me turn things over to you.
Richard F. Pops - Alkermes plc - Chairman & CEO
Thank you, Cory. Good morning, and good to see you. And hello to everybody on the virtual presentation. So this year's strategy, and therefore, this presentation, is focused on revealing and elaborating the value that's headed in this distinctive company. In 2020, we demonstrated the resiliency of our people and our business, and we added new scientific, financial and governance elements to the story. So 2021 is about focusing on translating all of this into a growing valuation. So on the
Alkermes Plc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers